Aktie 000999 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Aktien

000999

CNE0000011K8

000999

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 29.04.2024 		% 5 Tage % 1. Jan.
59,19 CNY -2,62 % Intraday Chart für China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. -1,37 % +19,02 %
19.04. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
25.03. Gewinn von CR Sanjiu steigt 2023 um 16,5%, Umsatz springt um 37% MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CR Sanjiu's 2023 Profit Climbs 16.5%, Revenue Jumps 37%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
China Resources Sanjiu Sees Up to 32% Jump in 2023 Profit
CR Sanjiu Expects Increase in 2023 Profit
Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. agreed to acquire 18.7751% stake in Runsheng Pharmaceutical Co., Ltd. from Chongqing Boyi Xintian Equity Investment Fund Partnership Enterprise (Limited Partnership), Tasly Capital and Chongqing Juxin Investment Co., Ltd. for CNY 58.9 million .
Respirent Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 127.97619 million in funding from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Chongqing Changsheng Shenghe Pharmaceutical Private Equity Investment Fund Partnership Enterprise
China Resources Power Unit to Provide Financial Assistance to Affiliate
CR Sanjiu Medical & Pharmaceutical Unit's Hypertension Drug Chosen for China's Centralized Procurement
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
China Resources Sanjiu to Invest Up to 3.5 Billion Yuan in Bank Financial Products
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CR Sanjiu Medical’s Analgesic Tablet Shortlisted For China’s Drug Procurement Program
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023
China Resources Sanjiu Medical & Pharmaceutical's Q1 Net Profit Surges
China Resources Power to Cooperate on New Energy Projects with China Resources Sanjiu Medical
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Enters into the Cooperation Agreement with China Resources Power Holdings Company Limited
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 000999 Aktie
  4. Nachrichten China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
  5. Andere Sprachen